Pharmaceutical Intermediate CAS 137234-62-9 Voriconazole Antifungal Voriconazole Powder Purity Voriconazole

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of US$ 350/kg
Request Sample
Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Management System Certification
ISO 9001, ISO 14001, GMP, HACCP
  • Pharmaceutical Intermediate CAS 137234-62-9 Voriconazole Antifungal Voriconazole Powder Purity Voriconazole
  • Pharmaceutical Intermediate CAS 137234-62-9 Voriconazole Antifungal Voriconazole Powder Purity Voriconazole
  • Pharmaceutical Intermediate CAS 137234-62-9 Voriconazole Antifungal Voriconazole Powder Purity Voriconazole
  • Pharmaceutical Intermediate CAS 137234-62-9 Voriconazole Antifungal Voriconazole Powder Purity Voriconazole
  • Pharmaceutical Intermediate CAS 137234-62-9 Voriconazole Antifungal Voriconazole Powder Purity Voriconazole
  • Pharmaceutical Intermediate CAS 137234-62-9 Voriconazole Antifungal Voriconazole Powder Purity Voriconazole
Find Similar Products
  • Overview
  • Product Description
  • Product Details
  • Application & Function
  • Specification
Overview

Basic Info.

Model NO.
Dsung-Voriconazole
Certification
GMP, HSE, ISO 9001, USP, BP
Suitable for
Elderly, Children, Adult
State
Powder
Purity
>99%
Product Name
Voriconazole
Name
Voriconazole Powder
Appearance
White to Almost White Crystalline Powder
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Pharmaceutical Intermediates
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
137234-62-9
Mf
C16h14f3n5o
MW
349.317
Density
1.42
Melting Point
127-130 C
Boiling Point
508.6 C at 760 Mmhg
Transport Package
Negotiable
Specification
99%
Trademark
D-Sung
Origin
Shaanxi
Production Capacity
5 Ton/Month

Product Description

Pharmaceutical Intermediate CAS 137234-62-9 Voriconazole Antifungal Voriconazole Powder Purity Voriconazole
Pharmaceutical Intermediate CAS 137234-62-9 Voriconazole Antifungal Voriconazole Powder Purity Voriconazole
 
Product Description

Pharmaceutical Intermediate CAS 137234-62-9 Voriconazole Antifungal Voriconazole Powder Purity VoriconazolePharmaceutical Intermediate CAS 137234-62-9 Voriconazole Antifungal Voriconazole Powder Purity Voriconazole

Product Details

Pharmaceutical Intermediate CAS 137234-62-9 Voriconazole Antifungal Voriconazole Powder Purity Voriconazole

Product Name Voriconazole
CAS No. 137234-62-9
MF C16H14F3N5O
MW 349.317
Appearance and shape White to almost white crystalline powder
Voriconazole is a broad-spectrum triazole antifungal ,it is primarily used for the treatment of  possibly life-threatening infections in immune deficiency patients. Indications include: immunosuppressed patients with severe fungal infections, acute invasive aspergillosis (the most common pathogen is Aspergillus fumigatus, followed by A. flavus, Aspergillus niger and Aspergillus soil), severe invasive infections caused by fluconazole-resistant Candida (including C. krusei) severe infection caused by Foot actinomycetes bacteria genus and Fusarium bacteria genus.
Application & Function

Pharmaceutical Intermediate CAS 137234-62-9 Voriconazole Antifungal Voriconazole Powder Purity VoriconazoleFyuunction
1. Voriconazoles is a triazole antifungal medication, it can cure empirical antifungal therapy.
2. Voriconazoles has become the new standard of care in the treatment of invasive aspergillosis.
3. Voriconazoles can used in the treat of esophageal candidiasis.
4. Voriconazoles has also been used to treat severe fungal corneal infection.
5. An antifungal (systemic). An ergosterol biosynthesis inhibitor.
Application
Voriconazoles is a broad-spectrum triazole antifungal ,it is primarily used for the treatment of progressive, possibly life-threatening infections in immune deficiency patients. Indications include: immunosuppressed patients with severe fungal infections, acute invasive aspergillosis (the most common pathogen is Aspergillus fumigatus, followed by A. flavus, Aspergillus niger and Aspergillus soil), severe invasive infections caused by fluconazole-resistant Candida (including C. krusei) severe infection caused by Foot actinomycetes bacteria genus and Fusarium bacteria genus . Moderate to severe renal insufficiency is administered intravenously paying caution.

Specification

Pharmaceutical Intermediate CAS 137234-62-9 Voriconazole Antifungal Voriconazole Powder Purity VoriconazolePharmaceutical Intermediate CAS 137234-62-9 Voriconazole Antifungal Voriconazole Powder Purity VoriconazolePharmaceutical Intermediate CAS 137234-62-9 Voriconazole Antifungal Voriconazole Powder Purity VoriconazolePharmaceutical Intermediate CAS 137234-62-9 Voriconazole Antifungal Voriconazole Powder Purity VoriconazolePharmaceutical Intermediate CAS 137234-62-9 Voriconazole Antifungal Voriconazole Powder Purity VoriconazolePharmaceutical Intermediate CAS 137234-62-9 Voriconazole Antifungal Voriconazole Powder Purity VoriconazolePharmaceutical Intermediate CAS 137234-62-9 Voriconazole Antifungal Voriconazole Powder Purity Voriconazole

 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier